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a b s t r a c t
High-risk human papillomavirus (HR HPV) oncoproteins bind host cell proteins to dysregulate and
uncouple apoptosis, senescence, differentiation, and growth. These pathways are important for both the
viral life cycle and cancer development. HR HPV16 E6 (16E6) interacts with the cellular protein NFX1-
123, and they collaboratively increase the growth and differentiation master regulator, Notch1. In 16E6
expressing keratinocytes (16E6 HFKs), the Notch canonical pathway genes Hes1 and Hes5 were
increased with overexpression of NFX1-123, and their expression was directly linked to the activation
or blockade of the Notch1 receptor. Keratinocyte differentiation genes Keratin 1 and Keratin 10 were also
increased, but in contrast their upregulation was only indirectly associated with Notch1 receptor
stimulation and was fully unlinked to growth arrest, increased p21Waf1/CIP1, or decreased proliferative
factor Ki67. This leads to a model of 16E6, NFX1-123, and Notch1 differently regulating canonical and
differentiation pathways and entirely uncoupling cellular arrest from increased differentiation.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Human Papillomaviruses (HPVs) are small double-stranded
DNA viruses that infect mucosa and cutaneous epithelium, and
the more than 100 genotypes of HPVs are divided into ﬁve genera.
The alpha genus of HPV is further subdivided into HPV types
termed low risk (LR HPV), which are associated with genital warts
and benign lesions, and high risk (HR HPV), which can cause
anogenital cancers. A long-term, persistent infection with a HR
HPV type is the greatest risk factor for cervical cancer develop-
ment (Moscicki et al., 2012;Rodriguez et al., 2010;Kjaer et al.,
2002), and therefore the manner by which HR HPV persists and
dysregulates its host cell, leading to cancer, is a focus of intensive
research.
HPV depends upon both epithelial differentiation and contin-
ued cell cycling to complete its life cycle, and these processes are
regulated by both the host cell and the virus (reviewed in (Doorbar
et al., 2012)). HPV ﬁrst infects the basal layer of stratiﬁed
squamous epithelium, typically through micro-abrasions or ana-
tomic epithelial transitions that expose these cells. Once the virus
infects a basal cell, the episomal viral DNA migrates to the nucleus
and is maintained at low copy numbers initially in proliferative
epithelial cells while viral early proteins are expressed. As epithe-
lial cells migrate to upper layers of stratiﬁed squamous epithelium,
the expression of late viral proteins is induced, and the viral
genome becomes ampliﬁed to thousands of copies per cell. Finally,
virion assembly is coupled to late cellular differentiation, and
infectious virus is released as host epithelial cells slough off.
Despite our understanding of the normal HPV viral life cycle and
normal epithelial differentiation, the molecular events that
directly regulate the switch from viral genome maintenance to
viral genome ampliﬁcation and productive infection in an HPV-
infected cell are not well understood, nor are the HPV-driven
disruptions of epithelial differentiation, cell cycling, and cellular
arrest pathways.
HR HPV type 16 (HPV 16) encodes two viral oncoproteins: E6
and E7. These oncoproteins perturb apoptosis and senescence by
degradation of tumor suppressors p53 and Rb, dysregulation of
angiogenesis, and modulation of keratinocyte growth and differ-
entiation. HPV 16E6 speciﬁcally partners with cellular proteins to
alter multiple epithelial and oncogenic pathways. One host cell
protein bound by 16E6 is the cytoplasmic protein NFX1-123
(Katzenellenbogen et al., 2007). NFX1-123 increases telomerase activ-
ity through post-transcriptional gene upregulation in HPV 16E6
expressing human foreskin keratinocytes (HFKs) (Katzenellenbogen
et al., 2009;Katzenellenbogen et al., 2007). Recently, our laboratory
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showed that NFX1-123 also synergizes with 16E6 to modulate
Notch1 protein and mRNA expression (Vliet-Gregg et al., 2013).
Both telomerase and Notch1 are important regulators of cellular
senescence, growth, and differentiation.
The mammalian Notch gene family encodes evolutionarily
conserved type 1 transmembrane receptors that play a key role
in cell fate determination and differentiation through cell-cell
communication (Borggrefe and Oswald, 2009;Watt et al., 2008).
The Notch family of cell surface receptors is comprised of four
transmembrane proteins (Notch1 to Notch4). In keratinocytes,
Notch1 and Notch2 are primarily expressed. During canonical
Notch1 signaling, ligands belonging to the Delta or Serrate/Jagged
family bind the Notch receptor, and the receptor is cleaved by the
gamma-secretase protease complex, releasing the Notch intracel-
lular domain (NICD), to translocate to the nucleus (Watt et al.,
2008). In the nucleus, NICD associates with the DNA binding
protein RBP-J (also known as CBF1) and its transcriptional coacti-
vator Mastermind (MAML), activating downstream targets such as
HES and HEY family members (Watt et al., 2008). Notch1 signaling
has been identiﬁed as both oncogenic and tumor suppressive in
cervical cancer development and progression, dependent on the
experimental design and cellular context (Yugawa et al., 2007;
Veeraraghavalu et al., 2004;Bajaj et al., 2011;Henken et al., 2012;
Lathion et al., 2003;Maliekal et al., 2008;Rangarajan et al., 2001;
Talora et al., 2002;Weijzen et al., 2003;Yugawa et al., 2010;
Zagouras et al., 1995).
In the present study, we investigate the roles Notch1 and NFX1-
123 each play in Notch canonical pathway regulation, differentia-
tion pathway regulation, and cellular growth and cycling in 16E6
HFKs. Endogenous NFX1-123 is expressed to a greater degree in
HPV positive cervical cancer cell lines than in HFKs, and when
16E6 HFKs are transduced to overexpress NFX1-123, we found
NFX1-123 had dual modes of action on the Notch canonical
pathway and the differentiation pathway. In these 16E6 HFKs,
increased NFX1-123 expression led to an augmented activation of
canonical pathway genes Hes1 and Hes5, and this occurred
directly through the Notch1 receptor. We also discovered that
overexpressed NFX1-123 upregulated the gene expression of
differentiation gene markers Keratin 1 and Keratin 10. However,
this increase in differentiation gene expression in 16E6 HFKs with
overexpressed NFX1-123 did not parallel the kinetics and magni-
tude of Notch canonical pathway gene activation, nor did it
depend fully on the Notch1 receptor. Finally, the enhancement of
the Notch canonical pathway and differentiation gene expression
did not trigger the expected concomitant increase in cell cycle
arrest or decrease in growth factor gene expression. The distinct
activation of Notch canonical pathway genes and differentiation
pathway genes by overexpressed NFX1-123 leads to a model of
direct and indirect pathway regulation, respectively. It also high-
lights an uncoupling of keratinocyte differentiation from cell cycle
exit in 16E6 HFKs through NFX1-123 overexpression, an unusual
cellular phenotypic state that may support HPV persistence and
cancer progression.
Results
NFX1-123 expression increased in cervical cancer cell lines
NFX1-123 and 16E6 and collaboratively regulate hTERTand Notch1
expression (Katzenellenbogen et al., 2007;Vliet-Gregg et al., 2013;
Katzenellenbogen et al., 2009), and both hTERT and Notch1 drive
cellular growth and malignant transformation (Katzenellenbogen
et al., 2010;Henken et al., 2012). As hTERT and Notch1 can be
increased in cervical cancer development and progression, we
hypothesized that NFX1-123 may also be increased in HPV positive
cervical cancer cell lines. Indeed, SiHa, CaSki, and HeLa cell lines all
had increased protein and mRNA NFX1-123 expression (Fig. 1A and
B). Therefore, because NFX1-123 levels were increased, we chose to
study further how a gain in NFX1-123 expression in 16E6 HFKs
would affect downstream Notch canonical, growth, and differentia-
tion pathways.
NFX1-123 and Notch1 regulation of canonical pathway genes
in 16E6 HFKs
We previously published that Notch1 expression was modulated
by the level of NFX1-123 in HFKs; 16E6 synergistically increased or
decreased Notch1 dependent on the amount of NFX1-123 expressed
(Vliet-Gregg et al., 2013). Multiple components of the Notch cano-
nical pathway, like Hes1 and Hes5, were increased in 16E6 HFKs
with greater NFX1-123, and were reduced when NFX1-123 was
knocked down by short-hairpin RNA (Vliet-Gregg et al., 2013).
Whether NFX1-123 drove expression of Hes1 and Hes5 directly
itself or through Notch1 and its canonical signaling pathway was
unclear, however.
To determine this, the Notch1 receptor was either blocked or
activated using the gamma secretase inhibitor DAPT or the ligand
Delta-Ligand 1 (DL1), respectively. This was done in 16E6 HFKs
transduced to overexpress NFX1-123 (16E6/FNFX1-123WT) or vec-
tor control (16E6/LXSN), noting that 16E6/FNFX1-123WT HFKs had
increased Notch1 when compared to 16E6/LXSN HFKs (Vliet-Gregg
et al., 2013). Cells were treated with DAPT to block cleavage of
membrane-bound Notch to its active, intracellular form. Cleaved
Notch1 (or NICD) was undetectable by whole cell extract immuno-
blot assay in both 16E6/FNFX1-123WT and 16E6/LXSN HFKs within
one hour of treatment when compared to vehicle control (dimethyl
sulfoxide (DMSO)) (Fig. 2A). With DMSO treatment, 16E6/FNFX1-
123WT HFKs had eightfold greater Hes1 mRNA and threefold
greater Hes5 mRNAwhen compared to 16E6 HFKs with endogenous
levels of NFX1-123 (16E6/LXSN) (Fig. 2B and C). However, when
Notch1 cleavage was blocked by DAPT, Hes1 and Hes5 mRNA in
16E6/FNFX1-123WT HFKs rapidly returned to amounts equivalent to
Fig. 1. NFX1-123 expression in epithelial cell lines. (A) Representative immunoblot
of NFX1-123 protein in whole cell extracts of HFKs and cervical cancer cell lines.
GAPDH was used as a loading control. (B) Relative levels of NFX1-123 mRNA
expression by qPCR. Error bars represent 95% conﬁdence intervals from the
technical triplicate replicates shown.
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16E6/LXSN HFKs (Fig. 2B and C). Notch1 mRNA itself was increased
eightfold in DMSO-treated 16E6/FNFX1-123WT HFKs versus 16E6/
LXSN HFKs; this too was reduced by more than half with DAPT
treatment (Fig. 2D). Without cleavage of Notch1 to its active
intracellular form, the sustained increase of Hes1, Hes5 and Notch1
mRNA in 16E6/FNFX1-123WT cells fell to the level of 16E6/LXSN
HFKs (Fig. 2B–D, DMSO vs DAPT 3 h).
The Notch1 receptor was then activated by culturing 16E6/
FNFX1-123WT or 16E6/LXSN HFKs in the presence of Delta-1
ligand (DL1) immobilized with retronectin or retronectin alone.
Ligand immobilization with retronectin is required for Notch
signal induction by DL1 (Varnum-Finney et al., 2000), with DL1
triggering Notch1 receptor activation and subsequent cleavage to
its intracellular, active form (NICD). Hes1 and Hes5 expression had
a robust and rapid induction in response to Notch1 receptor
activation by DL1, increasing within three hours. In 16E6/FNFX1-
123WT cells this mRNA increase was more than sixty times greater
for Hes1 and thirty times higher for Hes5 than in 16E6/LXSN HFKs
(Fig. 3A and B). Notch1 mRNA also increased more than two
hundredfold within three hours of culture with DL1 (Fig. 3C and
D). Notch1, Hes1 and Hes5 mRNA did increase in 16E6/LXSN HFKs
cultured with DL1, but this did not occur until 24 h (Fig. 3A–C).
Therefore, when triggered by DL1, increased NFX1-123 and Notch1
expression in 16E6/FNFX1-123WT HFKs led to greater and more
rapid induction of Hes1, Hes5, and Notch1 when compared to
16E6/LXSN cells. Using retronectin without DL1, there was no
change in Hes1, Hes5, or Notch1 transcript levels in 16E6/LXSN
HFKs, but in 16E6/FNFX1-123WT HFKs where Notch1 is persis-
tently increased, there were modest increases in Hes1, Hes5, and
Notch1 mRNA levels (Fig. 3A–D). These Notch canonical pathway
studies, where Notch1 receptor was blocked or activated collec-
tively, support the conclusion that NFX1-123 requires Notch1 itself
to drive expression of Hes1 and Hes5, and when NFX1-123 itself is
overexpressed it leads to a sustained greater Notch1 expression
and therefore more dramatic and rapid activation or reduction in
Notch canonical pathway targets.
Differentiation gene expression but not p21WAF1/Cip1 increased by
NFX1-123 in 16E6 HFKs
We previously conducted a microarray study to determine
genes modulated by NFX1-123 in 16E6 HFKs (Vliet-Gregg et al.,
2013). Data from this microarray study, analyzed using Gene
Ontology terms for Biological Process classiﬁcation, revealed that
epidermal and keratinocyte differentiation were pathways signiﬁ-
cantly perturbed through NFX1-123 overexpression in 16E6 HFKs
when compared to an isogenic scramble shRNA control (Fig. 4A).
Genes found to be increased twofold or more by microarray
analysis that supported these identiﬁed pathway changes included
the keratinocyte differentiation markers late corniﬁed envelope
proteins (LCEs), loricrin, and small proline rich proteins (SPRRs)
(noted in model, Fig. 4B) (Vliet-Gregg et al., 2013). Because the
epidermal and keratinocyte differentiation pathways were signiﬁ-
cantly upregulated in the microarray study, we chose to quantify
gene expression changes of several markers that should be
increased during keratinocyte differentiation: Keratin 1 and Ker-
atin 10 (early markers of differentiation in stratiﬁed squamous
epithelium), and Loricrin (increased in our microarray) (under-
lined in Fig. 4B) (Vliet-Gregg et al., 2013). FNFX1-123WT HFKs
with no 16E6 co-expression had only a subtle increase in Keratin
1 mRNA, one-and-a-halffold, when compared to isogenic scramble
shRNA control cells (scramble). Keratin 10 and Loricrin mRNAwere
moderately increased, up to fourfold in these cells (Fig. 4C, left
panel). These genes in 16E6/FNFX1-123WT HFKs revealed
enhanced expression, seven- to-thirtyfold, of Keratin 1, Keratin
10 and Loricrin mRNA compared to 16E6/scramble cells (Fig. 4C,
right panel). Therefore, 16E6 co-expression led to greater levels of
Keratin 1, Keratin 10, and Loricrin in HFKs with overexpressed
NFX1-123.
Surprisingly, while mRNA expression of differentiation marker
genes were increased and differentiation pathways were signiﬁ-
cantly altered when NFX1-123 was overexpressed in 16E6 HFKs,
genes involved in cell cycle regulation were unperturbed. We found
no evidence for increases in cell cycle arrest genes by microarray
(Vliet-Gregg et al., 2013) or subsequent Gene Ontology analyses. To
conﬁrm this, we quantiﬁed the expression of p21WAF1/Cip1, a cell cycle
arrest gene. The p21WAF1/Cip1 gene is directly activated by p53 and by
Notch1 (Rangarajan et al., 2001;Warfel and El-Deiry, 2013) to trigger
cell cycle arrest. It is known that p21WAF1/Cip1 expression is reduced
in 16E6 expressing cells through p53 degradation and inactivation of
Fig. 2. Chemical inhibition of Notch1 abrogated canonical pathway components.
(A) Representative immunoblot of cleaved Notch1 protein in 16E6 HFKs transduced
with overexpressed FLAG-tagged NFX1-123 wild type (FNFX1-123WT) or LXSN
vector control. Whole cell extracts from 16E6/LXSN and 16E6/FNFX1-123WT
treated with either DMSO or 10 mM DAPT were prepared at the indicated times.
Actin was used as a loading control. Similar results were obtained in two additional
experiments. (B) Relative levels of Hes1 mRNA (C) Hes5 mRNA, and (D) Notch1
mRNA were calculated using the ΔΔCT method, normalizing mRNA levels to
GAPDH within each sample. Values shown were the mean fold change in each
sample compared to the DMSO treated 16E6/LXSN vector control. Error bars
represent the standard deviation for triplicate samples.
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the p150 transcription factor (Huibregtse et al., 1991;Parroche et al.,
2011;Scheffner et al., 1993). We wanted to determine if 16E6 affected
p21WAF1/Cip1 levels in cells overexpressing NFX1-123, and if p21WAF1/
Cip1 levels were modulated by the augmented Notch1 expression in
16E6/FNFX1-123WT HFKs. As expected, p21WAF1/Cip1 mRNA was
detected in vector control (pBABE) HFKs, and it was reduced by half
when 16E6 was expressed (Fig. 4D). In 16E6/FNFX1-123WT HFKs
there was no change in p21WAF1/Cip1 mRNA expression when
compared to 16E6/LXSN HFKs (Fig. 4D), despite greater Notch1 and
differentiation gene expression (Vliet-Gregg et al., 2013) and Figs. 2–
4. We also found no change in Cyclin A, B1, or E protein expression in
16E6/FNFX1-123WT HFKs when compared to cells with endogenous
levels of NFX1-123 (Fig. 4E). Higher levels of NFX1-123 (FNFX1-
123WT) increased keratinocyte differentiation gene expression and
was further increased by 16E6 co-expression in HFKs, but surpris-
ingly this was not accompanied by concomitant cell cycle arrest or
senescence as marked by p21WAF1/Cip1 expression.
Regulation of differentiation and cell cycle arrest pathway genes by
NFX1-123 and Notch1 in 16E6 HFKs
Notch1 functions as a master regulator of growth and differen-
tiation in keratinocytes and during cervical cancer development
(Maliekal et al., 2008;Henken et al., 2012;Lathion et al., 2003;
Rangarajan, Syal et al., 2001;Rangarajan et al., 2001;Zagouras et al.,
1995). Because NFX1-123 increases Notch1 expression in 16E6 HFKs,
and greater levels of Notch1 may drive increased differentiation
marker expression and pathway activation, it was important to
determine if increased differentiation gene expression and pathway
changes in 16E6/FNFX1-123WT HFKs occurred directly via Notch1
receptor activation, similar to the Notch canonical pathway genes
Hes1 and Hes5. As a corollary, we wanted to elucidate whether
activation or blockade of the Notch1 receptor in 16E6/FNFX1-123WT
and 16E6/LXSN HFKs led to interlinked regulation of differentiation
and cell cycle arrest or whether they were fully uncoupled.
To explore this, we expanded on our previous studies and
treated 16E6/FNFX1-123WT or 16E6/LXSN HFKs with DAPT to
block Notch1 receptor cleavage and activation, and serially col-
lected lysates for quantitation of both differentiation and cell cycle
arrest genes. The proﬁle of Keratin 1 and Keratin 10 mRNA changes
did not parallel those of the Notch1 canonical pathway genes Hes1
and Hes5 (compare Fig. 2B and C and Fig. 5A and B). In both 16E6/
FNFX1-123WT and 16E6/LXSN HFKs, there was no decrease in
differentiation marker gene expression with inhibition of Notch1
activation. In fact, at three hours of DAPT treatment in 16E6/LXSN
HFKs, the transcript levels of Keratin 1 and Keratin 10 increased
(Fig. 5A and B). Furthermore, the cell cycle arrest gene p21WAF1/Cip1
mRNA was unchanged when Notch1 cleavage was blocked
(Fig. 5C). When later time points were evaluated, no decrease or
increase in Keratin 1, Keratin 10 or p21WAF1/Cip1 mRNA levels was
identiﬁed (data not shown). Therefore, differentiation marker and
cell cycle arrest gene expression did not depend on activated,
cleaved Notch1 in either 16E6 cell type.
When Notch1 receptor was activated by immobilized DL1, Keratin1
and Keratin 10 increased, but the kinetics of their increased expression
were dramatically different than the Notch canonical pathway target
genes Hes1 and Hes5 (compare Fig. 6 and Fig. 3). At three hours,
Keratin 1 and Keratin 10 had a less robust increase in expression that
continued to rise at 24 h, unlike Hes1 and Hes5 (Fig. 6A and B). Also,
only 16E6/FNFX1-123WT HFKs had an increase in Keratin 1 and
Keratin 10 levels when activated by DL1, as those cells had greater
baseline Notch1 expression. Finally, we found p21 WAF1/Cip1 mRNA fell
over the course of DL1 activation (Fig. 6C). So, Notch1 activation by DL1
did slowly lead to moderate increases in differentiation gene expres-
sion, but only in cells with greater Notch1 expression (16E6/FNFX1-
123WT HFKs, Fig. 6 vertical striped bars), and activation of Notch1 did
not trigger increased p21WAF1/Cip1 expression.
Fig. 3. DL1 activated Notch1 canonical pathway signaling. 16E6/LXSN and 16E6/FNFX1-123WT HFKs were plated on dishes coated with puriﬁed Delta-1 ligand (DL1)
immobilized on retronectin or retronectin alone. Whole cell extracts were harvested for RNA and protein at the indicated times. Similar results were found in at least three
independent experiments. (A) Relative levels of Hes1 mRNA (B) Hes5 mRNA and (C) Notch1 mRNA were calculated using the ΔΔCT method, normalizing mRNA levels to
GAPDH within each sample. Values shown were the mean fold change in each sample compared to the 16E6/LXSN vector control plated on retronectin. Error bars represent
the standard deviation for triplicate samples. (D) Representative immunoblot of Notch1 protein in whole cell extracts of 16E6/LXSN and 16E6/FNFX1-123WT HFKs at the
indicated times. Actin shown as a loading control.
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Fig. 4. FNFX1-123WT induced differentiation markers in 16E6 HFKs. (A) Top statistically signiﬁcant Gene Ontology (GO) terms for Biological Process classiﬁcation of the
differentially increased gene expression comparing 16E6 HFKs transduced with overexpressed FLAG-tagged NFX1-123 wild type (FNFX1-123WT) and isogenic scramble
short hairpin RNA control (scramble). (B) Markers of differentiation in stratiﬁed squamous epithelium. The expression of keratins and other structural proteins shift with
differentiation. (Illustration adapted from Hoffjan and Stemmler (2007)). (C) HFKs and 16E6 HFKs transduced with FNFX1-123WT or a scramble shRNA control were analyzed
by qPCR. Relative levels of Keratin1, Keratin10 and Loricrin mRNA were calculated using the ΔΔCT method, normalizing mRNA levels to GAPDH within each sample. Values
shown are the mean fold change in each sample compared to the scramble vector control. Error bars represent the standard deviation for triplicate samples. (D) HFKs
transduced with 16E6 or a vector control (pBABE), and then FNFX1-123WT or a second vector control (LXSN), were analyzed for p21Waf1/CIP1 mRNA levels using the
housekeeping gene 36B4 as control. Values shown were the mean fold change in each sample compared to the scramble vector control. Error bars represent 95% conﬁdence
intervals from the technical triplicate replicates shown. (E) Representative immunoblot of Cyclin A, B1, and E protein in whole cell extracts of 16E6/LXSN and 16E6/FNFX1-
123WT HFKs. GAPDH shown as a loading control.
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No growth suppression with increased differentiation gene expression
by NFX1-123 in 16E6 HFKs
Higher NFX1-123 and Notch1 protein and mRNA expression did
not increase the cell cycle arrest gene p21WAF1/Cip1 in 16E6 HFKs
(Figs. 4D and 6C) However, we wanted to assess if other genes
involved in growth or proliferation were repressed, leading to
slowed growth or cell cycle blockade in 16E6/FNFX1-123WT HFKs
compared to 16E6/LXSN HFKs. Additionally, there may be subsets
of 16E6/FNFX1-123WT HFKs that express greater amounts of
differentiation markers and concomitantly do not express prolif-
eration markers, but this difference was undetectable when
averaged across a population of cells. To address these issues, we
quantiﬁed differentiation gene and growth marker expression on a
cell-by-cell basis in 16E6/FNFX1-123WT and 16E6/LXSN HFKs.
To evaluate whether there were differences in cell growth and
proliferation factor expression in cells with greater NFX1-123,
16E6/FNFX1-123WT and 16E6/LXSN HFKs were stained for Ki67.
We found 96% of 16E6/LXSN HFKs to be Ki67 positive, and this
remained unchanged when NFX1-123 was overexpressed (16E6/
FNFX1-123WT) (Fig. 7A and B). Therefore equal numbers of 16E6
HFKs expressed Ki67 irrespective of NFX1-123 levels. These cells
were then co-stained for Keratin 1 and Ki67 to assess whether
there were cells with greater differentiation marker gene expres-
sion that segregated into separate populations from cells with
growth factor expression. Keratin 1 protein expression was nearly
twofold greater in 16E6/FNFX1-123WT HFKs than in 16E6/LXSN
HFKs, and its staining was homogeneous across the cell population
(Fig. 7C and D). Again, as in Fig. 7A and B, more than 95% of 16E6
HFKs expressed Ki67 regardless of the expression level of NFX1-
123 or Keratin 1 (Fig. 7C and D). Therefore, nearly all 16E6 HFKs
with increased NFX1-123 still expressed a proliferation factor,
Ki67, even as NFX1-123, Notch1, and differentiation markers, such
as Keratin 1, were increased.
Normal cell cycle progression in 16E6 HFKs with increased NFX1-123
Even with similar p21WAF1/Cip1 and Ki67 expression in 16E6/
FNFX1-123WT and 16E6/LXSN HFKs, the rate of cell cycle progres-
sion in 16E6/FNFX1-123WT HFKs might be slowed with both
increased Notch1 and differentiation pathway gene expression.
We performed cell cycle analysis using ﬂuorescence-activated cell
sorting to compare the cell cycle proﬁles of density arrested and
released 16E6/FNFX1-123WT HFKs to 16E6/LXSN HFKs. Interest-
ingly both of these cell types were cycling, and there was no
slowing in 16E6/FNFX1-123WT HFKs (Fig. 8A). In fact, a greater
fraction of 16E6/FNFX1-123WT HFKs were already in G2 at four
hours after release when compared to 16E6/LXSN, and by six
hours, a greater number of 16E6/FNFX1-123WT HFKs had returned
to G1 when compared to 16E6/LXSN HFKs (Fig. 8B). 16E6 HFKs
with overexpressed NFX1-123 had increased Notch1, canonical
pathway, and differentiation gene expression but had uncoupled
the typical reﬂexive activation of cell cycle arrest shown by
unchanged p21, Ki67, and cell cycle proﬁles.
Discussion
These studies identiﬁed a separation in gene and pathway
regulation for 16E6 HFKs with increased expression of NFX1-123.
In 16E6 HFKs, Notch1, Notch canonical pathway genes Hes1 and
Hes5, and differentiation pathway genes Keratin 1 and Keratin 10
were all altered by greater NFX1-123 expression. However, NFX1-
123 in these cells did not increase p21WAF1/Cip1 mRNA, change Ki67
expression, or cause cell cycle arrest. These ﬁndings lead to a dual-
faceted model of pathway regulation by NFX1-123 and Notch1 in
16E6 HFKs (Fig. 9). NFX1-123 regulates Notch1 expression in an
augmented manner in 16E6 cells. When the Notch1 receptor is
activated by DL1, Hes1, Hes5, and Notch1 mRNA expression quickly
increase (Fig. 3). This ﬁrst mode of action on the canonical pathway
is rapid, suggesting that the effect is directly due to Notch1 and
NFX1-123. Consistent with this, when the Notch1 receptor cleavage
and activation was blocked by gamma secretase inhibitor, the
increased expression of Hes1 and Hes5 mRNA fell rapidly to the
level of 16E6 HFKs with endogenous expression levels of NFX1-123
(Fig. 2). These data point again to NFX1-123 driving Hes1 and Hes5
expression through activated, cleaved Notch1. They also point to
Notch1 regulating its own expression when it is cleaved and
activated or chemically blocked (Fig. 2D, 3C and D). We propose
that the greater activation of Hes1, Hes5, and Notch1 expression in
16E6/FNFX1-123WT HFKs compared to 16E6/LXSN HFKs is due to
the greater level of full length Notch1 found in these cells. With more
Notch1 receptor available for activation by DL1, more cleaved Notch
can be produced, leading to the direct, rapid, and robust downstream
Fig. 5. Differentiation markers unperturbed by chemical inhibition of Notch1 in
16E6 HFKs with overexpressed NFX1-123. 16E6 HFKs transduced with overex-
pressed FLAG-tagged NFX1-123 wild type (FNFX1-123WT) or LXSN vector control
treated with either DMSO or 10 mM DAPT were prepared at the indicated times.
Similar results were obtained in three independent experiments. (A) Relative levels
of Keratin 1 mRNA and (B) Keratin 10 mRNA were calculated using the ΔΔCT
method, normalizing mRNA levels to GAPDH within each sample. Values shown
were the mean fold change in each sample compared to the DMSO treated 16E6/
LXSN vector control. Error bars represent the standard deviation for triplicate
samples. (C) Transcript levels for p21Waf1/CIP1 were assessed by quantitative real-
time PCR using primers and normalized to the housekeeping gene 36B4 as control.
Values shown were the mean fold change in each sample compared to the DMSO
treated 16E6/LXSN vector control. Error bars represent 95% conﬁdence intervals
from the technical triplicate replicates shown.
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gene target response, and when Notch1 receptor is blocked, the fall
in its downstream genes is also fast.
Conversely, the differentiation pathway is regulated in 16E6
HFKs by NFX1-123 and Notch1 in a mode distinct from the
canonical pathway. Keratin 1 and Keratin 10 mRNA expression
are unperturbed by blocking cleavage of Notch1 in 16E6/FNFX1-
123WT HFKs (Fig. 5). However, when Notch1 was activated by DL1,
Keratin 1 and Keratin 10 expression were increased in 16E6/
FNFX1-123WT HFKs (Fig. 6). The activation proﬁles of these
differentiation markers were more gradual and less robust than
the canonical pathway genes, which depended on the overexpres-
sion of NFX1-123 and Notch1. Keratin 1 and Keratin 10 did not
increase in 16E6 HFKs with endogenous levels of NFX1-123 and
Notch1. In our model of 16E6 HFKs, Notch1 has an indirect effect
on the differentiation pathway and its genes only when NFX1-123
is overexpressed.
Fig. 6. Notch1 stimulation by DL1 activated differentiation markers in 16E6 HFKs with overexpressed NFX1-123. 16E6/LXSN and 16E6/FNFX1-123WT HFKs were plated on
dishes coated with puriﬁed Delta-1 ligand (DL1) immobilized on retronectin or retronectin alone. Whole cell extracts were harvested for RNA and protein at the indicated
times. Similar results were found in at least three independent experiments. (A) Relative levels of Keratin 1 mRNA and (B) Keratin 10 mRNA were calculated using the ΔΔCT
method, normalizing mRNA levels to GAPDH within each sample. Values shownwere the mean fold change in each sample compared to the 16E6/LXSN vector control plated
on retronectin. Error bars represent the standard deviation for each triplicate. (C) Transcript levels for p21Waf1/CIP1 were assessed by quantitative real-time PCR using primers
and normalized to the housekeeping gene 36B4 as control. Values shown were the mean fold change in each sample compared to the DMSO treated 16E6/LXSN vector
control. Error bars represent 95% conﬁdence intervals from the technical triplicate replicates shown.
Fig. 7. Ki67 expression unchanged with overexpression of FNFX1-123WT and increased Keratin 1. Immunoﬂuorescent staining was done in 16E6 HFKs transduced with
overexpressed FLAG-tagged NFX1-123 wild type (FNFX1-123WT) or LXSN vector control. (A) Ki67 staining of 16E6/LXSN HFKs and (B) 16E6/FNFX1-123WT HFKs.
Bar¼10 μm; Green¼Ki67; Blue¼TO-PRO3, nuclear stain. Quantiﬁcation of percent positive Ki67 expression by immunoﬂuorescent staining was done in three independent
16E6 HFK cell lines with increased NFX1-123 (FNFX1-123WT) versus three vector control (LXSN) HFKs. Expression pattern of the indicated protein was assessed by dual
immunohistochemical (IHC) analysis of pelleted, ﬁxed, parafﬁn embedded cells. (C) 16E6/LXSN HFKs and (D) 16E6/FNFX1-123WT HFKs stained for Ki67 and Keratin1 (K1).
Green¼Ki67; Blue¼DAPI; Red¼Keratin 1. Similar results were observed in three independent experiments using three distinct 16E6 HFK cell lines.
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Fig. 8. Cell cycle unchanged in 16E6 HFKs expressing increased NFX1-123. BrdU pulse-chase experiment in 16E6 HFKs transduced with overexpressed FLAG-tagged NFX1-
123 wild type (FNFX1-123WT) or LXSN vector control. Cells were synchronized by density arrest, released in BrdU for one hour, then chased in BrdU-free media for the
indicated times. Cells were stained with Propidium Iodide (PI) and cell cycle progression was monitored by FACS analysis. Similar results were found in least three
independent HFK cell line experiments. (B) Graphical representation of ﬂow cytometry analysis.
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Finally, an uncoupling of Notch1 and differentiation pathway
upregulation from growth arrest in 16E6 HFKs was also identiﬁed
in our studies. There was no evidence of an upregulation in growth
arrest genes in our microarray screen when 16E6 HFKs with
overexpressed NFX1-123 were compared to those with endogen-
ous levels of NFX1-123 (Vliet-Gregg et al., 2013). Additionally no
difference was found in expression of p21WAF1/Cip1(Fig. 4), despite
it being a Notch1 regulated gene, and there was no decrease in
percent of Ki67 expression in cells or cell cycle rates in 16E6/
FNFX1-123WT HFKs (Figs. 7 and 8). There was no heterogeneity in
growth factor or differentiation gene expression among 16E6/FNFX1-
123WT and 16E6/LXSN HFKs at a population level or on a cell-by-cell
basis, and 16E6 HFKs with greater expression of NFX1-123 progressed
normally through the cell cycle, if not faster than 16E6/LXSN HFKs.
This suggests that 16E6 cells with greater NFX1-123 expression
increase Notch pathway canonical and differentiation genes while
concurrently avoiding cell cycle exit and growth arrest.
It is well-known that HPV requires epithelial cells to both
divide and differentiate during its viral life cycle, but it is less clear
if cellular division and differentiation happen simultaneously
within the same cell or whether these changes occur separately
in distinct layers of stratiﬁed squamous epithelium. Recent studies
support our ﬁndings and have found increased Notch1 expression
co-occurring with both an increased growth potential and differ-
entiation marker expression in cervical cancer cell lines as well as in
HFKs expressing HPV 31 (Pattabiraman et al., 2014). Additionally, the
parsing of differentiation and growth arrest pathways has been seen in
the context of 16E7 expression (Lefort et al., 2007;Muller et al., 1999;
Nguyen et al., 2006), so there is precedence for an HPV oncoprotein
uncoupling differentiation from cellular growth.
The increases we found in differentiation pathway regulation
by Gene Ontology (Fig. 4A), and differentiation gene expression
(Fig. 4C) required greater NFX1-123 expression and were speciﬁ-
cally augmented by 16E6 co-expression. In a microarray study we
conducted of non-16E6 expressing HFKs, two differentiation genes
had twofold or greater mRNA levels with overexpression of NFX1-
123 alone (GEO (GSE43082)); these genes plus several more were
increased when NFX1-123 was overexpressed and 16E6 was co-
expressed (Vliet-Gregg et al., 2013). These ﬁndings support a
hypothesis that NFX1-123 regulates the keratinocyte differentia-
tion pathway, and this is synergistically increased by 16E6 while
avoiding changes to cell growth.
Greater NFX1-123 (typically overexpressed threefold in 16E6/
FNFX1-123WT HFKs) drives augmented hTERT expression and telo-
merase activity (Katzenellenbogen et al., 2007;Katzenellenbogen et al.,
2009), and clinically greater telomerase activity parallels worsening
cervical disease (Ault t al., 2005;Branca et al., 2006). Increased NFX1-
123 expression may be an important driver of both telomerase
activation and cellular dysregulation with high risk E6, and the
combination of increased NFX1-123 with 16E6 affecting host cells'
differentiation and growth pathways is important to study. Additional
studies are on-going to examine the mechanism by which NFX1-123
and 16E6 increase differentiation gene expression collaboratively,
the factors that link Notch1 and differentiation directly or indirectly
through NFX1-123 and 16E6, and how these changes inﬂuence the
HPV viral life cycle.
Conclusions
Our ﬁndings point to a model of keratinocytes where HR HPV
oncogenes – speciﬁcally HPV 16E6 – and increased NFX1-123 lead to
greater Notch1 and canonical pathway gene expression as well as
differentiation pathway gene expression, while entirely untethering
them from concomitant growth arrest. This cellular phenotype, driven
by NFX1-123 expression, may lead to both growth and differentiation
within the same cell and an ideal host cell environment for a long-
lived and productive HPV infection.
Material and methods
Microarray
Microarray analysis has been previously described and is
accessible through GEO (GSE43082) (Vliet-Gregg et al., 2013).
Biological interpretation using Gene Ontology was performed
using GeneSpring GX11.5.1 (Agilent Technologies, Santa Clara, CA).
Tissue culture
Primary human foreskin keratinocytes (HFKs) were cultured as
described previously (Gewin et al., 2004). Brieﬂy, HFKs were
derived from neonatal foreskins and grown in EpiLife medium
supplemented with calcium chloride (60 μM), human keratinocyte
growth supplement (Life Technologies, Carlsbad, CA), and penicil-
lin–streptomycin. HFKs cultured for cyclin detection were treated
with 10 mM of MG132 (Sigma, Saint Louis, MO), two hours prior to
harvest of whole cell protein extracts. 293T cells were grown in
Dulbecco's modiﬁed Eagle's medium (GIBCO-BRL, Carlsbad, CA)
containing 10% fetal bovine serum and penicillin–streptomycin.
Retrovirus production and infection
Retrovirus was produced in 293T cells by a transient vesicular
stomatitis virus G-pseudotyped virus (VSV-G) production protocol as
previously described (Bartz and Vodicka, 1997). Lentivirus was also
produced as previous described (Katzenellenbogen et al., 2007).
Retrovirus and lentivirus was serially collected, concentrated by
ultracentrifuge, mixed with Polybrene (8 μg/mL) (EMD Millipore,
Billerica, MA), and incubated with 50 to 60% conﬂuent HFKs. Three
hours later, the Epilife medium was replaced. For VSV-G pseudotyped
virus infections (FNFX1-123WT, LXSN vector control, pBabe-puro
16E6) the cells were expanded 24 h post-transduction, and after
48 h the cells were placed under neomycin/G418 selection (50 μg/
mL) or puromycin selection (0.5 μg/mL). All lentivirus infections
(scramble) were conﬁrmed by green ﬂuorescent protein expression.
Quantitative real-time PCR and Taqman array
Total RNA was isolated with TRIzol reagent (Life Technologies,
Carlsbad, CA). Total RNA (1 mg) was DNase treated and used to
generate cDNA with random hexamer primers and SuperScript II
reverse transcriptase (Life Technoloiges, Carlsbad, CA). Quantitative
Fig. 9. Model of 16E6 and NFX1-123WT regulation of Notch1, Notch canonical
pathway genes and keratinocyte differentiation pathway genes.
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real-time PCR was performed using an ABI StepOne Plus system
(Applied Biosystems, Foster City, CA). Ampliﬁcation was carried
out using TaqMan master mix and the following pre-designed
Taqman probes: GAPDH (4333764F), KRT1 (Hs00196158_m1), KRT10
(Hs00166289), LOR (HS01894962_s1), Notch1 (HS01062014_m1),
HES1 (Hs00172878_m1), and HES5 (Hs01387463_g1) according to
the manufacturer's instructions (Applied Biosystems, Foster City, CA).
Reactions were performed in triplicate. Data analysis was performed
using the comparative threshold cycle method (Applied Biosystems,
Foster City, CA) to determine relative expression levels, with GAPDH
to normalize mRNA levels within each sample. Values graphed are
the mean fold-change in each sample compared to control, and error
bars graphed represent the standard deviation for each sample
(n¼3). Primer sequences for NFX1-123, p21Waf1/CIP1 and 36B4 were
described previously (McDade et al., 2011;Katzenellenbogen et al.,
2007). Ampliﬁcation was carried out as previously published
(Katzenellenbogen et al., 2007) using Power Sybr Green Master Mix
(Life Technologies, Foster City, CA. Error bars using NFX1-123, p21Waf1/
CIP1 and 36B4 primers represent 95% conﬁdence intervals.
Immunoblotting
Western Blots were performed as described previously
(Vliet-Gregg et al., 2013). Blots were probed with the following
antibodies: actin (I-19) (1:1000; Scbt, Santa Cruz, CA), Cleaved
Notch1 (Val1744) (1:1000; Cell Signaling, Danvers, MA), Cyclin A
(H432) (1:500; Scbt, Santa Cruz, CA), Cyclin B1 (GNS1) (1:500;
Scbt, Santa Cruz, CA), Cyclin E (C-19) (1:500; Scbt, Santa Cruz, CA),
GAPDH (1:100,000, Abcam, Cambridge, MA) and Notch1 (5B5)
(1:1000; Cell Signaling, Danvers, MA). The rabbit polyclonal anti-
NFX1-123 antibody was generously provided by Dr. Ann Roman.
Immunoﬂuorescence
16E6 HFK cell lines were cultured on glass coverslips and grown to
60% conﬂuency as described previously (Katzenellenbogen et al.,
2009). Cells were then ﬁxed with 4% paraformaldehyde, permeabilized
and stained with Ki67 antibody VP-K451 (1:1000 for 60 min, Vector
Laboratories, Burlingame, CA) and TO-PRO3 nuclear stain (Life Tech-
nologies, Carlsbad, CA), as previously described (Katzenellenbogen
et al., 2009). Confocal microscopy was conducted as previously
described (Katzenellenbogen et al., 2009). For the Ki67 expression
rates, more than 700 cells for both LXSN-expressing and FLAG-NFX1-
123-expressing HFKs were counted. Ki67 expression was determined
manually, and the percent of Ki67þ cells (Ki67þcells/total cells) and
95% conﬁdence intervals were calculated using Excel (Redmond, WA).
Dual Immunohistochemistry
16E6 HFKs were grown in culture, rinsed with warm PBS,
scraped off tissue culture plates, and centrifuged. The cell pellet
was washed in PBS and resuspended in 10% neutral buffered
formalin. The cell pellet was ﬁxed for three to ﬁve days at 4 1C
and embedded in parafﬁn for staining. Antigen was retrieved by
Trilogy steamer for 20 min with a 20 min cool down. Cells were
blocked with TCT Buffer and stained with Ki67 MIB1 (1:50 for
60 min; Dako M7240, Carpinteria, CA), Keratin 1 (1:200 for
60 min; Covance PRB-149 P, Princeton, NJ), or an isogenic IgG
control. Cells were counterstained with DAPI. Confocal microscopy
was conducted as previously described (Katzenellenbogen et al.,
2009). Mean gray scale value of Keratin 1 was quantiﬁed on
Z-stack cell projections using ImageJ. Images were quantiﬁed after
adjustment to isotype control threshold values.
Delta-1 ligand and gamma secretase inhibitor treatment
Chemical inhibition of Notch signaling was done by treating
cells with 10 mM gamma secretase inhibitor IX, DAPT (DAPT,
565784, Millipore, Billerica, MA). Delta-1 ligand (DL1) was pro-
duced as previously described (Varnum-Finney et al., 2000) and
was a generous gift from Dr. Colleen Delaney for Notch1 activation.
Brieﬂy, 2.5 mg/mL of DL1 and 5 mg/mL of retronectin [a vehicle that
is required for immobilizing Delta-1 ligand to the non-coated
tissue culture plate] or retronectin alone as a control (Takara/
Clontech, Mountain View, CA) were diluted in chilled PBS, coated
onto non-tissue culture treated plates at 0.16 mL/cm2 and kept
overnight at 4 1C. Keratinocytes were then plated the following
day after washing the plates with PBS. All experiments were done
in keratinocytes at 50–60% conﬂuency in culture because Notch
signaling occurs between adjacent cells and cell–cell contact is an
inducer of keratinocyte differentiation in culture. Keratinocytes
used for these experiments were also of equivalent passages and
were never cultured beyond passage 15.
Fluorescence-activated cell sorter (FACS) analysis
For the pulse chase experiments, cells were synchronized by
growing to conﬂuence and waiting an additional 24 h before
release. Cells were released and labeled with 200 mM BrdU for
one hour, chased in BrdU-free media, and collected at indicated
times. Cells were harvested by trypsinization and pelleted by
centrifugation. All centrifugation steps were done for ﬁve minutes
at 1000g. Cell pellets were resuspended in cold phosphate-
buffered saline (PBS); and while being vortexed, samples were
ﬁxed by the addition of cold 95% ethanol for overnight storage at
4 1C. Nuclei were isolated from ﬁxed cells by incubating pellets
with 3 mL of 0.08% pepsin, for 20 min at 37 1C. Samples were then
pelleted by centrifugation and the supernatant was aspirated.
Nuclei were resuspended, while being vortexed, with 1.5 mL 2 M
HCl and incubated for 15 min at 37 1C. Twice the original sample
volume of 0.1 M Sodium Borate was then added while vortexing.
Nuclei were pelleted by centrifugation and the supernatant was
aspirated. The resulting pellet was then resuspended, with con-
tinuous vortexing, in 2 mL IFA (150 mM NaCl, 4% fetal bovine
serum, 0.1% sodium azide) plus 5% Tween20. Samples were once
again pelleted by centrifugation and the supernatant was aspi-
rated. Nuclei were stained with ﬂuorescein isothiocyanate (FITC)
conjugated anti-BrdU antibody (Becton Dickinson, Franklin Lakes,
NJ), for 30 min on ice. Nuclei were pelleted, supernatant removed,
and resulting pellet was resuspended in 250 mL of 5 mg/ml RNase A
dissolved in IFA, transferred to 12 by 75-mm snap cap tubes, and
incubated at 37 1C for 15 min. Following incubation, 250 mL of
100 mg propidium iodide (PI) per ml was added. Nuclei were then
analyzed using a BD FACS Scan instrument (Becton Dickinson) and
FlowJo software (Ashland, OR).
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